Subscribe

Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Biotechnology

A collection of 10 Posts

Biotech Innovators Dualitas, AllRock Secure Series A Funding; PharmEasy Raises Debt for Restructuring post image
biotech venture-capital funding Biotechnology digital-health Digital Health

Biotech Innovators Dualitas, AllRock Secure Series A Funding; PharmEasy Raises Debt for Restructuring

by Newsdesk
NeOnc Technologies Advances Brain Cancer Drug NEO212 to Phase II Clinical Trial post image
Brain Cancer Clinical Trials Biotechnology

NeOnc Technologies Advances Brain Cancer Drug NEO212 to Phase II Clinical Trial

Featured post
by Newsdesk
BioVersys Reports Strong H1 2025 Progress in Antibacterial Drug Development post image
Pharmaceuticals Drug Development Biotechnology Clinical Trials Clinical Research

BioVersys Reports Strong H1 2025 Progress in Antibacterial Drug Development

Featured post
by Newsdesk
NKGen Biotech Completes NKMax Acquisition, Boosts Cell Therapy Ambitions post image
Biotechnology Acquisition Cell Therapy Alzheimer's Disease Pharmaceuticals Corporate Finance Healthcare Innovation

NKGen Biotech Completes NKMax Acquisition, Boosts Cell Therapy Ambitions

Featured post
by Newsdesk
Novartis acquires Tourmaline Bio from the US post image
Novartis Tourmaline Bio Pharmaceuticals Biotechnology Acquisition Business News

Novartis acquires Tourmaline Bio from the US

Featured post
by Newsdesk
Ultragenyx Pharmaceutical (NASDAQ:RARE) Receives Overweight Rating from Cantor Fitzgerald post image
Biotechnology Pharmaceuticals Stock Market Investment Analysis Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical (NASDAQ:RARE) Receives Overweight Rating from Cantor Fitzgerald

by Newsdesk
BioMarin Pharmaceutical Attracts New Institutional Investment Amidst Positive Analyst Outlook post image
Biotechnology Pharmaceuticals Stock Market Investment Institutional Investors Market Analysis

BioMarin Pharmaceutical Attracts New Institutional Investment Amidst Positive Analyst Outlook

Featured post
by Newsdesk
Northstrive and YuvaBio Complete Phase II of AI Program for Obesity & Cardiometabolic Therapies post image
Biotechnology AI Drug Discovery Obesity Research Cardiometabolic Disease MitoNova Platform

Northstrive and YuvaBio Complete Phase II of AI Program for Obesity & Cardiometabolic Therapies

by Newsdesk
XORTX Therapeutics to Host Investor Webinar and Q&A on September 10 post image
XORTX Therapeutics Investor Webinar Pharmaceuticals Biotechnology Corporate Event

XORTX Therapeutics to Host Investor Webinar and Q&A on September 10

by Newsdesk
Artelo Biosciences Announces Proposed Underwritten Public Offering post image
Artelo Biosciences Public Offering Pharmaceuticals Biotechnology Capital Raise

Artelo Biosciences Announces Proposed Underwritten Public Offering

by Newsdesk